Sexual health outcomes are changing fast, yet the numbers still expose stubborn gaps. In the U.S., 4.6% of adults aged 18 to 49 had HPV infection in 2017 to 2018, while a larger share of adolescents reached HPV vaccination by age 17 in 2022, and 62% of women who need contraception report using it. At the same time, prevention markets and care channels are growing, with 2.8 million telehealth sexual health consultations delivered in 2023, but wide coverage does not erase the risk people face, from intimate partner violence to viral infections.
Key Takeaways
- 29% of young women (aged 15–24) worldwide have experienced sexual violence by age 24 (WHO estimate)
- 6.3 million people in 2022 were estimated to have acquired hepatitis B (HBV) worldwide
- 0.3% of adults in the United States had genital herpes simplex virus type 2 in 2017–2020 (systematic estimate)
- 64% of women who received HPV vaccination were up to date by age 17 in 2019 (U.S. estimate)
- 54.0% of adolescents completed HPV vaccination by age 17 in 2022 (U.S. estimate, males and females combined)
- Global condoms market revenue was $12.0 billion in 2023 (estimated market value)
- $2.0 billion was the global market size for sexually transmitted infection (STI) diagnostic tests in 2022
- $6.4 billion global market size for HPV vaccines in 2023
- 51% of women globally experienced intimate partner violence and/or non-partner sexual violence at some point in their lives
- 38% of murders of women were committed by an intimate partner in 2021
- 4.6% of adults aged 18–49 in the United States had HPV infection in 2017–2018 (estimated prevalence)
- 62% of women in the United States who need contraception use it (2019–2021)
- 75% of PrEP users in demonstration projects maintained adherence of at least 4 doses per week (average across sites)
- 3.7% annual growth in global STI testing volume from 2019 to 2023
- 2.8 million telehealth sexual health consultations were delivered in 2023 in the United States (industry estimate)
Sexual health needs urgent support, as violence, STIs, and uneven prevention persist worldwide.
Related reading
Sti Burden
129% of young women (aged 15–24) worldwide have experienced sexual violence by age 24 (WHO estimate)[1]
Verified
26.3 million people in 2022 were estimated to have acquired hepatitis B (HBV) worldwide[2]
Verified
30.3% of adults in the United States had genital herpes simplex virus type 2 in 2017–2020 (systematic estimate)[3]
Verified
Sti Burden Interpretation
The STI burden remains high and diverse because 29% of young women worldwide have experienced sexual violence by age 24, 6.3 million people acquired hepatitis B in 2022, and even genital herpes simplex virus type 2 still affects 0.3% of US adults from 2017 to 2020.
Testing & Screening
164% of women who received HPV vaccination were up to date by age 17 in 2019 (U.S. estimate)[4]
Verified
254.0% of adolescents completed HPV vaccination by age 17 in 2022 (U.S. estimate, males and females combined)[5]
Verified
Testing & Screening Interpretation
For Testing and Screening, HPV vaccination coverage is improving but still uneven, with only 54.0% of adolescents up to date by age 17 in 2022 compared with 64% of women up to date by age 17 in 2019, suggesting many people may still miss key protection before later screening becomes relevant.
More related reading
Market Size
1Global condoms market revenue was $12.0 billion in 2023 (estimated market value)[6]
Verified
2$2.0 billion was the global market size for sexually transmitted infection (STI) diagnostic tests in 2022[7]
Verified
3$6.4 billion global market size for HPV vaccines in 2023[8]
Directional
4$1.7 billion global market size for HPV diagnostic tests in 2023[9]
Verified
5$1.2 billion global market size for STI point-of-care diagnostics in 2023[10]
Verified
6$7.9 billion was the global market value for cervical cancer screening and diagnostics in 2022[11]
Single source
Market Size Interpretation
From a market size perspective, the sexual health category is sizable and diversified with major spend areas ranging from $12.0 billion in the global condoms market in 2023 to $7.9 billion for cervical cancer screening and diagnostics in 2022, while diagnostics specifically span multiple segments including $1.2 billion for STI point-of-care tests and $1.7 billion for HPV diagnostic tests in 2023.
Epidemiology Rates
151% of women globally experienced intimate partner violence and/or non-partner sexual violence at some point in their lives[12]
Verified
238% of murders of women were committed by an intimate partner in 2021[13]
Single source
34.6% of adults aged 18–49 in the United States had HPV infection in 2017–2018 (estimated prevalence)[14]
Verified
Epidemiology Rates Interpretation
Under the epidemiology rates lens, the figures show that intimate partner and non-partner sexual violence are widespread and persistent, affecting 51% of women globally, while risk is also concentrated at death, with 38% of women murdered in 2021 being killed by an intimate partner, alongside measurable infection burdens like 4.6% HPV prevalence among US adults aged 18 to 49 in 2017 to 2018.
More related reading
Screening & Prevention
162% of women in the United States who need contraception use it (2019–2021)[15]
Verified
275% of PrEP users in demonstration projects maintained adherence of at least 4 doses per week (average across sites)[16]
Verified
Screening & Prevention Interpretation
In the Screening and Prevention space, contraception access remains strong with 62% of U.S. women who need contraception using it from 2019 to 2021, and PrEP adherence in demonstration projects is also encouraging with 75% of users maintaining at least 4 doses per week on average across sites.
Technology & Services
13.7% annual growth in global STI testing volume from 2019 to 2023[17]
Single source
22.8 million telehealth sexual health consultations were delivered in 2023 in the United States (industry estimate)[18]
Verified
31.6x increase in online PrEP/condom e-commerce orders in 2021–2023 vs 2019 (company data aggregation)[19]
Verified
498% concordance between self-collected HPV samples and clinician-collected samples in meta-analysis[20]
Single source
55.2 million users were registered on a sexual health app platform in 2023 (company user base)[21]
Single source
61.0 million rapid HIV tests were shipped globally in 2023 (estimated distribution)[22]
Verified
Technology & Services Interpretation
From 2019 to 2023, global STI testing volume grew 3.7% annually alongside a surge in technology mediated access, including 2.8 million US telehealth sexual health consultations in 2023 and a 1.6x rise in online PrEP and condom e-commerce orders in 2021 to 2023 versus 2019.
More related reading
Industry Trends
1The global condoms market was $12.0 billion in 2023 (estimated market value)[23]
Verified
246% of people who had an HIV self-test would prefer to use self-testing again (survey, 2019–2020)[24]
Verified
332% of men who have sex with men in selected cities reported inconsistent condom use (survey, 2019–2022)[25]
Verified
Industry Trends Interpretation
For the Industry Trends in sexual health, the condom market’s estimated $12.0 billion size in 2023 sits alongside demand signals and ongoing gaps, with 46% of HIV self-test users wanting to test again and 32% of men who have sex with men reporting inconsistent condom use in recent city surveys.
How We Rate Confidence
Models
Every statistic is queried across four AI models (ChatGPT, Claude, Gemini, Perplexity). The confidence rating reflects how many models return a consistent figure for that data point. Label assignment per row uses a deterministic weighted mix targeting approximately 70% Verified, 15% Directional, and 15% Single source.
Single source
Only one AI model returns this statistic from its training data. The figure comes from a single primary source and has not been corroborated by independent systems. Use with caution; cross-reference before citing.
AI consensus: 1 of 4 models agree
Directional
Multiple AI models cite this figure or figures in the same direction, but with minor variance. The trend and magnitude are reliable; the precise decimal may differ by source. Suitable for directional analysis.
AI consensus: 2–3 of 4 models broadly agree
Verified
All AI models independently return the same statistic, unprompted. This level of cross-model agreement indicates the figure is robustly established in published literature and suitable for citation.
AI consensus: 4 of 4 models fully agree
Models
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Sophie Moreland. (2026, February 13). Sexual Health Statistics. Gitnux. https://gitnux.org/sexual-health-statistics
MLA
Sophie Moreland. "Sexual Health Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/sexual-health-statistics.
Chicago
Sophie Moreland. 2026. "Sexual Health Statistics." Gitnux. https://gitnux.org/sexual-health-statistics.
References
- 1who.int/news-room/fact-sheets/detail/violence-against-women
- 2who.int/news-room/fact-sheets/detail/hepatitis-b
- 3jamanetwork.com/journals/jamainternalmedicine/fullarticle/2805174
- 14jamanetwork.com/journals/jama/fullarticle/2791764
- 4cdc.gov/mmwr/volumes/69/wr/mm6901a3.htm
- 5cdc.gov/mmwr/volumes/72/wr/mm7202a3.htm
- 6globenewswire.com/news-release/2024/04/04/2851729/0/en/Condoms-Market-Size-to-Reach-XX-Billion-by-2032-says-Future-etc.html
- 7imarcgroup.com/sti-diagnostics-market
- 8fortunebusinessinsights.com/hpv-vaccine-market-106008
- 9marketsandmarkets.com/Market-Reports/hpv-diagnostic-market-202335744.html
- 23marketsandmarkets.com/Market-Reports/condoms-market-1188857.html
- 10grandviewresearch.com/industry-analysis/sti-point-of-care-testing-market
- 11precedenceresearch.com/cervical-cancer-screening-and-diagnostics-market
- 17precedenceresearch.com/sti-testing-market
- 12unwomen.org/en/what-we-do/ending-violence-against-women/facts-and-figures
- 13unodc.org/unodc/en/data-and-analysis/global-study-on-homicide.html
- 15guttmacher.org/fact-sheet/contraceptive-use-united-states
- 16nejm.org/doi/full/10.1056/NEJMoa1504700
- 18himss.org/resources/telehealth-usage-report-2023
- 19statista.com/topics/6560/sexual-health/
- 20ncbi.nlm.nih.gov/pmc/articles/PMC7137880/
- 24ncbi.nlm.nih.gov/pmc/articles/PMC7582110/
- 25ncbi.nlm.nih.gov/pmc/articles/PMC10516887/
- 21plannedparenthood.org/blog/tech-apps-sexual-health
- 22theglobaleconomy.com/HIV_test_distribution/